News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
287,466 Results
Type
Article (15335)
Company Profile (300)
Press Release (271825)
Multimedia
Podcasts (79)
Webinars (11)
Section
Business (81225)
Career Advice (177)
Deals (13576)
Drug Delivery (39)
Drug Development (51323)
Employer Resources (32)
FDA (6069)
Job Trends (5270)
News (147665)
Policy (10388)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (951)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (22037)
ALS (124)
Alzheimer's disease (1033)
Antibody-drug conjugate (ADC) (247)
Approvals (6270)
Artificial intelligence (262)
Autoimmune disease (110)
Automation (10)
Bankruptcy (106)
Best Places to Work (4643)
BIOSECURE Act (6)
Biosimilars (100)
Biotechnology (230)
Bladder cancer (108)
Brain cancer (46)
Breast cancer (353)
Cancer (3170)
Cardiovascular disease (240)
Career advice (161)
Career pathing (8)
CAR-T (219)
CDC (5)
Cell therapy (566)
Cervical cancer (14)
Clinical research (44228)
Collaboration (1159)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1133)
CRISPR (86)
C-suite (554)
Cystic fibrosis (112)
Data (4364)
Denatured (16)
Depression (92)
Diabetes (257)
Diagnostics (1488)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (214)
Earnings (32186)
Editorial (25)
Employer branding (5)
Employer resources (30)
Events (52478)
Executive appointments (621)
FDA (7842)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (989)
Gene editing (183)
Generative AI (21)
Gene therapy (490)
GLP-1 (508)
Government (1205)
Grass and pollen (3)
Guidances (169)
Healthcare (6787)
HIV (24)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (66)
Infectious disease (1237)
Inflammatory bowel disease (159)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (167)
Interviews (20)
IPO (7429)
IRA (12)
Job creations (891)
Job search strategy (141)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (9)
Legal (1483)
Liver cancer (44)
Longevity (11)
Lung cancer (427)
Lymphoma (249)
Machine learning (24)
Management (7)
Manufacturing (375)
MASH (130)
Medical device (2800)
Medtech (2810)
Mergers & acquisitions (6779)
Metabolic disorders (729)
Multiple sclerosis (103)
NASH (13)
Neurodegenerative disease (229)
Neuropsychiatric disorders (70)
Neuroscience (1954)
Neurotech (1)
NextGen: Class of 2026 (2108)
Non-profit (903)
Now hiring (30)
Obesity (331)
Opinion (129)
Ovarian cancer (131)
Pain (105)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (303)
Patient recruitment (328)
Peanut (43)
People (27142)
Pharmaceutical (45)
Pharmacy benefit managers (6)
Phase 1 (15558)
Phase 2 (20477)
Phase 3 (13101)
Pipeline (3277)
Policy (91)
Postmarket research (902)
Preclinical (6586)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (648)
Real estate (1496)
Recruiting (12)
Regulatory (10103)
Reports (20)
Research institute (988)
Resumes & cover letters (19)
Rett syndrome (24)
RNA editing (21)
RSV (16)
Schizophrenia (123)
Series A (183)
Series B (136)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (121)
Sponsored (17)
Startups (2021)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (19)
The Weekly (62)
Vaccines (340)
Venture capital (69)
Weight loss (174)
Women's health (25)
Worklife (2)
Date
Last 7 days (347)
Last 30 days (1162)
Last 365 days (17973)
2026 (1665)
2025 (18279)
2024 (20813)
2023 (22747)
2022 (27300)
2021 (28242)
2020 (23802)
2019 (16686)
2018 (12136)
2017 (14075)
2016 (12144)
2015 (14752)
2014 (10643)
2013 (7685)
2012 (7735)
2011 (7847)
2010 (7641)
Location
Africa (166)
Alabama (65)
Alaska (3)
Arizona (74)
Arkansas (5)
Asia (18518)
Australia (3153)
California (7105)
Canada (1841)
China (777)
Colorado (252)
Connecticut (253)
Delaware (240)
Europe (40155)
Florida (920)
Georgia (212)
Hawaii (2)
Idaho (17)
Illinois (398)
India (35)
Indiana (163)
Iowa (8)
Japan (236)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (740)
Massachusetts (5613)
Michigan (115)
Minnesota (252)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (32)
New Hampshire (21)
New Jersey (1676)
New Mexico (13)
New York (1772)
North Carolina (844)
North Dakota (6)
Northern California (3486)
Ohio (180)
Oklahoma (11)
Oregon (24)
Pennsylvania (1320)
Puerto Rico (9)
Rhode Island (27)
South America (229)
South Carolina (9)
Southern California (2816)
Tennessee (41)
Texas (916)
United States (23566)
Utah (96)
Virginia (136)
Washington D.C. (38)
Washington State (594)
West Virginia (1)
Wisconsin (45)
287,466 Results for "lam therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Orphai Therapeutics’ Phase 2a LAM-001 Study Selected for Oral Presentation at the American Thoracic Society (ATS) 2026 International Conference
January 21, 2026
·
2 min read
Insights
From Nuclear Winter to Renewal: Biotech Investing for 2026
In this episode of Denatured, Jennifer C. Smith-Parker speaks to Maha Katabi, general partner at Sofinnova Investments and Andrew Lam, managing director, head of Biotech Private Equity at Ally Bridge Group, about how M &A dynamics, dealmaking and global partnerships are reshaping portfolio valuations and paths to growth in 2026.
January 8, 2026
·
1 min read
·
Jennifer Smith-Parker
Drug Development
AI Therapeutics Announces Investigator Initiated Phase 2 Trial at UCSF to Study LAM-001 in Patients With Bronchiolitis Obliterans Syndrome (BOS) Post-Lung Transplant
AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the commencement of an investigator initiated Phase 2 study at UC San Francisco (UCSF) for its novel inhaled form of sirolimus, LAM-001, for the treatment of bronchiolitis obliterans syndrome (BOS) in patients post-lung transplant.
August 18, 2023
·
3 min read
Drug Development
AI Therapeutics Announces Initiation of a Phase 2 Clinical Trial of LAM-001 for Treatment of Pulmonary Arterial Hypertension (PAH)Potential new disease modifying treatment for a rare, progressive, and life-threatening cardiopulmonary disease
AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the initiation of a Phase 2 study for its novel inhaled form of sirolimus, LAM-001, for the treatment of pulmonary arterial hypertension (PAH).
August 31, 2023
·
3 min read
Press Releases
Laminar Pharma Announces first open-label Progression-Free Survival data for LAM561 in combination with standard of Care in First-Line Therapy for Newly Diagnosed Glioblastoma MGMT-methylated patients
March 6, 2025
·
7 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Press Releases
Altamira Therapeutics to Present at mRNA-Based Therapeutics Summit
January 26, 2026
·
4 min read
Press Releases
Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations
October 2, 2025
·
4 min read
Press Releases
Lexeo Therapeutics Announces Key Leadership Appointments Strengthening Cardiovascular Expertise Alongside Updates to Strategic Partnership for Novel Cardiac RNA Therapeutics
January 28, 2026
·
7 min read
Press Releases
Silexion Therapeutics to Attend 7th Annual RNAi-Based Therapeutics Summit
January 22, 2026
·
1 min read
1 of 28,747
Next
